survival

You have access
Clinical Prognostic Factors for Local Control and Survival After Irradiation of Grade II Gliomas
JASPAR WITTELER, STEVEN E. SCHILD and DIRK RADES

In Vivo November 2020, 34 (6) 3719-3722; DOI: https://doi.org/10.21873/invivo.12220
You have access
High Paip1 Expression as a Potential Prognostic Marker in Hepatocellular Carcinoma
HAYEON KIM, WONKYUNG JUNG, AEREE KIM, HAN KYEOM KIM and BAEK-HUI KIM

In Vivo September 2020, 34 (5) 2491-2497; DOI: https://doi.org/10.21873/invivo.12065
You have access
Prognostic and Clinical Implications of WNK Lysine Deficient Protein Kinase 1 Expression in Patients With Hepatocellular Carcinoma
YI-JUNG HO, JUNGSHAN CHANG, KUN-TU YEH, ZHIYUAN GONG, YUEH-MIN LIN and JENG-WEI LU

In Vivo September 2020, 34 (5) 2631-2640; DOI: https://doi.org/10.21873/invivo.12081
You have access
Prognostic Role of the Platelet-to-Lymphocyte Ratio for Patients With Metastatic Colorectal Cancer Treated With Aflibercept
AKIHISA MATSUDA, TAKESHI YAMADA, SATOSHI MATSUMOTO, SEIICHI SHINJI, RYO OHTA, HIROMICHI SONODA, ERIKO SHINOZUKA, KUMIKO SEKIGUCHI, HIDEYUKI SUZUKI and HIROSHI YOSHIDA

In Vivo September 2020, 34 (5) 2667-2673; DOI: https://doi.org/10.21873/invivo.12086
You have access
Pre-Treatment Seizures in Patients With 1-3 Cerebral Metastases Receiving Local Therapies Plus Whole-brain Radiotherapy
JASPAR WITTELER, TROELS W. KJAER, SOEREN TVILSTED, STEVEN E. SCHILD and DIRK RADES

In Vivo September 2020, 34 (5) 2727-2731; DOI: https://doi.org/10.21873/invivo.12094
You have access
Assessment of Systemic Inflammatory Response and Nutritional Markers in Patients With Trastuzumab-treated Unresectable Advanced Gastric Cancer
TSUTOMU NAMIKAWA, MASAHIRO MAEDA, KEIICHIRO YOKOTA, NOBUHISA TANIOKA, IAN FUKUDOME, JUN IWABU, MASAYA MUNEKAGE, SUNAO UEMURA, HIROMICHI MAEDA, HIROYUKI KITAGAWA, MICHIYA KOBAYASHI and KAZUHIRO HANAZAKI

In Vivo September 2020, 34 (5) 2851-2857; DOI: https://doi.org/10.21873/invivo.12112
You have access
Cytoplasmic CK1ε Protein Expression Is Correlated With Distant Metastasis and Survival in Patients With Melanoma
JENG-WEI LU, SHU-HUI LIN, CHUNG-MIN YEH, KUN-TU YEH, LAN-RU HUANG, CHIA-YU CHEN and YUEH-MIN LIN

In Vivo September 2020, 34 (5) 2905-2911; DOI: https://doi.org/10.21873/invivo.12119
You have access
Increased Expression of p-GSK3β Predicts Poor Survival in T –III/IV Stage OSCC Patients
BHARATH KUMAR VELMURUGAN, CHUN-WEN CHIU, YUEH-MIN LIN, MAHALAKSHMI BHARATH, CHUNG-MIN YEH, YU-EN CHEN, CHIA-MIN CHUNG and SHU-HUI LIN

In Vivo July 2020, 34 (4) 1805-1809; DOI: https://doi.org/10.21873/invivo.11975
You have access
Histopathological Features and Ann Arbor Stage in Periocular Lymphoma
MARCO ZSCHOCHE, ANNETTE ZIMPFER, BJÖRN O. SCHEEF, ANSELM M. JÜNEMANN, RUDOLF F. GUTHOFF, CHRISTIAN JUNGHANSS, GUIDO HILDEBRANDT, STEFFEN EMMERT, ANDREAS ERBERSDOBLER, GÜNTHER KUNDT and VINODH KAKKASSERY

In Vivo July 2020, 34 (4) 1965-1974; DOI: https://doi.org/10.21873/invivo.11993
You have access
The Number of Harvested LNs Is an Independent Prognostic Factor in Lymph Node Metastasis-negative Patients Who Received Curative Esophagectomy
TORU AOYAMA, YOSUKE ATSUMI, SHINNOSUKE KAWAHARA, HIROSHI TAMAGAWA, AYAKO TAMAGAWA, YUKIO MAEZAWA, KAZUKI KANO, MASAAKI MURAKAWA, KEISUKE KAZAMA, MASAKATSU NUMATA, TAKASHI OSHIMA, NORIO YUKAWA, MUNETAKA MASUDA and YASUSHI RINO

In Vivo July 2020, 34 (4) 2021-2027; DOI: https://doi.org/10.21873/invivo.12001

Main menu

User menu

Search

survival

Pages